Raloxifene in postmenopausal osteopenic women with mild asymptomatic primary hyperparathyroidism

被引：0
|
作者：
Zanchetta, JR
Bogado, CE
机构：
[1] Inst Invest Metabol, Buenos Aires, DF, Argentina
[2] USAL Univ, Sch Med, Buenos Aires, DF, Argentina
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
552
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [1] Clinical vignette - Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism
    Zanchetta, JR
    Bogado, CE
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) : 189 - 190
  • [2] Effests of raloxifene hydrocholoride in postmenopausal osteopenic and osteoporotic women
    Ilter, Erdin
    Tufekci, Can E.
    Karalok, Hakan
    Batur, Osman
    Akyol, Hurkan
    [J]. MEDICAL JOURNAL OF BAKIRKOY, 2005, 1 (01) : 20 - 28
  • [3] Raloxifene: is it really effective on mood changes in postmenopausal osteopenic women?
    Karsidag, A. Yasemin Karageyim
    Karsidag, Cagatay
    Buyukbayrak, Esra Esim
    Kars, Bulent
    Pirimoglu, Meltem
    Unal, Orhan
    Turan, M. Cem
    [J]. JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY, 2010, 31 (04): : 273 - 278
  • [4] Asymptomatic and mild primary hyperparathyroidism
    Macfarlane, David P.
    Yu, Ning
    Leese, Graham P.
    [J]. ANNALES D ENDOCRINOLOGIE, 2015, 76 (02) : 120 - 127
  • [5] Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women
    Delmas, P. D.
    Davis, S. R.
    Hensen, J.
    Adami, S.
    van Os, S.
    Nijland, E. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (08) : 1153 - 1160
  • [6] Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism
    Rubin, MR
    Lee, KH
    McMahon, DJ
    Silverberg, SJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03): : 1174 - 1178
  • [7] Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women
    P. D. Delmas
    S. R. Davis
    J. Hensen
    S. Adami
    S. van Os
    E. A. Nijland
    [J]. Osteoporosis International, 2008, 19 : 1153 - 1160
  • [8] On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism
    Dempster, DW
    Parisien, M
    Silverberg, SJ
    Liang, XG
    Schnitzer, M
    Shen, V
    Shane, E
    Kimmel, DB
    Recker, R
    Lindsay, R
    Bilezikian, JP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05): : 1562 - 1566
  • [9] Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism
    Bolland, Mark J.
    Grey, Andrew B.
    Orr-Walker, Brandon J.
    Horne, Anne M.
    Evans, Margaret C.
    Clearwater, Judy M.
    Gamble, Greg D.
    Reid, Ian R.
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2008, 121 (1277) : 18 - 29
  • [10] NEUROMUSCULAR INVOLVEMENT IN MILD, ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM
    TURKEN, SA
    CAFFERTY, M
    SILVERBERG, SJ
    DELACRUZ, L
    CIMINO, C
    LANGE, DJ
    LOVELACE, RE
    BILEZIKIAN, JP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 87 (05): : 553 - 557
12345